key: cord-0295710-9118sev5
authors: Blanquart, F.; Hoze, N.; Cowling, B. J.; Debarre, F.; Cauchemez, S.
title: Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants
date: 2021-12-09
journal: nan
DOI: 10.1101/2021.12.08.21267454
sha: bfcf4573f4383bcc557cb3bedfb3c52be7f6c446
doc_id: 295710
cord_uid: 9118sev5

Evaluating the characteristics of emerging SARS-CoV-2 variants of concern is essential to inform pandemic risk assessment. A variant may grow faster if it produces a larger number of secondary infections (transmissibility advantage) or if the timing of secondary infections (generation time) is better. So far, assessments have largely focused on deriving the transmissibility advantage assuming the generation time was unchanged. Yet, knowledge of both is needed to anticipate impact. Here we develop an analytical framework to investigate the contribution of both the transmissibility advantage and generation time to the growth advantage of a variant. We find that the growth advantage depends on the epidemiological context (level of epidemic control). More specifically, variants conferring earlier transmission are more strongly favoured when the historical strains have fast epidemic growth, while variants conferring later transmission are more strongly favoured when historical strains have slow or negative growth. We develop these conceptual insights into a statistical framework to infer both the transmissibility advantage and generation time of a variant. On simulated data, our framework correctly estimates both parameters when it covers time periods characterized by different epidemiological contexts. Applied to data for the Alpha and Delta variants in England and in Europe, we find that Alpha confers a +54% [95% CI, 45-63%] transmissibility advantage compared to previous strains, and Delta +140% [98-182%] compared to Alpha, and mean generation times are similar to historical strains for both variants. This work helps interpret variant frequency and will strengthen risk assessment for future variants of concern.

Evaluating the characteristics of emerging SARS-CoV-2 variants of concern is essential to 18 inform pandemic risk assessment. A variant may grow faster if it produces a larger number of 19 secondary infections (transmissibility advantage) or if the timing of secondary infections 20 (generation time) is better. So far, assessments have largely focused on deriving the 21 transmissibility advantage assuming the generation time was unchanged. Yet, knowledge of 22

both is needed to anticipate impact. Here we develop an analytical framework to investigate 23 the contribution of both the transmissibility advantage and generation time to the growth 24 advantage of a variant. We find that the growth advantage depends on the epidemiological 25 context (level of epidemic control). More specifically, variants conferring earlier transmission 26 are more strongly favoured when the historical strains have fast epidemic growth, while 27 variants conferring later transmission are more strongly favoured when historical strains have 28 slow or negative growth. We develop these conceptual insights into a statistical framework to 29 infer both the transmissibility advantage and generation time of a variant. On simulated data, 30 our framework correctly estimates both parameters when it covers time periods characterized 31 by different epidemiological contexts. Applied to data for the Alpha and Delta variants in 32 England and in Europe, we find that Alpha confers a +54% [95% CI, 45-63%] transmissibility 33 advantage compared to previous strains, and Delta +140% [98-182%] compared to Alpha, and 34 mean generation times are similar to historical strains for both variants. This work helps 35 interpret variant frequency and will strengthen risk assessment for future variants of concern. 36 Introduction investigate how the growth advantage may vary with the epidemiological context when 69 variants have different generation times. We use the relationship between infectivity profile 70 and growth rate to explore conceptually how infectivity profiles are selected for. We find that 71 the growth advantage of a variant generally depends on the epidemiological context, more 72 precisely on whether transmission is low (declining or slow epidemic) or high (fast epidemic). 73

We call transmission the rate of infectious contacts in the community, which depends on the 74 epidemiological context, for example social distancing, mask-wearing, population immunity, 75 seasonal effects, etc. We use the time-varying reproduction number of the historical strain 76 (taken as a reference), denoted " ( ), as a proxy for transmission. Our conceptual exploration 77 suggests that it is possible to infer changes in infectivity profile associated with an emerging 78 variant, and not only its growth rate, in settings where transmission changes over time. We thus 79 develop an inference framework to estimate changes in infectivity profile associated with a 80 variant and more precisely characterize the transmissibility advantage of the variant and its 81 dependency to the epidemiological context. We apply our approach to data on Alpha and Delta 82 variants frequency over time in England in Fall 2020 and Spring 2021. 83

General principle 85 We consider a situation where a variant, or a set of strains with similar properties, have been 86 circulating for some time (historical strains H) and is challenged by an emerging variant E. 87

When investigating the rise of variant E relative to historical strains H, we typically only 88 observe the exponential growth rates of H and E strains, which translates into a growth 89 advantage (or disadvantage). More precisely, if the historical strains grow with exponential rate 90 " and the emerging variant grows with rate ' , the logit of the frequency of the emerging 91 variant will grow linearly with slope ' − " . This slope is called the growth advantage or is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. shorter or longer mean generation time, the relative mean generation time is -15% or +15% compared to historical 163 strains. For variants with shorter or longer sd in generation time, the relative sd in generation time is -40% or 164 +40% compared to historical strains. The Panels C, D show for these variants, the selection coefficient as a 165 function of the proxy for transmission (effective reproduction number of the historical strains is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint Our inference framework is based on the relationship between growth rates of historical strains 185 ( " ) and of the emerging variant ( ' ). Our aim is to infer three parameters > , ? , @ , 186 characterizing respectively the transmissibility advantage, the mean generation time and the sd 187 With this statistical framework at hand, we conducted a simulation study to infer jointly the 202 transmissibility advantage of the variants and their relative mean generation time ( Figure 3 ). In 203 these simulations, we systematically varied the infectivity profile of the emerging strain: 204 transmissibility advantage ( > ) from +0 to +50% and relative mean generation time ( ? ) from 205 -40% to +40%. We assumed the emerging strain had the same sd of generation time as 206 historical strains ( @ = 0). We jointly inferred the two parameters > and ? for different 207 sample sizes (sample size, N = 1000, 3000, 10000 per day) and for different scenarios of 208 variability in epidemiological context, from a strong to a weak decline. In the explicit 209 simulations, the parameter that we tune is the basic reproductive number 5," ( ) assumed to 210 decline from 1.5 to 0.5, 1.3 to 0.7 and 1.1 to 0.9 over 80 days in the three scenarios, and the 211 inferred parameters represent the effective reproductive number after accounting for population 212 immunity and case detection and isolation (Supplementary Figure 2) . 213

The transmissibility advantage was almost always precisely inferred even with small sample 214 size and small variability in effective reproduction number (Figure 3 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint error on ' and " due to the limited sample size, in conjunction with the small variability in 218 5," ( ) makes precise inference of the relationship between ' and " difficult. For such small 219 sample sizes, grouping data by week (instead of by days, for the same duration) improves 220 inference ( is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint generation time we used a variant transmissibility advantage of > = +30% or > = +45% (for relative mean 230 generation time ? = +20% and ? = +40%). For each parameter combination, 10 replicate simulations were 231 drawn with the same parameters, hence the same deterministic epidemiological dynamics, but with different 232 random error on data (Poisson error on cases number and binomial error on frequencies).

Application to the variants Alpha and Delta in England 234 We used this framework to infer the transmissibility advantage and mean generation time of In an attempt to gain more power to disentangle the transmissibility advantage from the mean 253 generation time for the Delta variant, we used spatial variation in growth rates across European 254 countries. We used data from the European Surveillance System (TESSy) on the growth rate 255 of "historical" strains circulating at the time when Delta emerged (mainly Alpha variant), and 256 the emerging Delta variant across 11 European countries with sufficient genomic data (Austria, 257

Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Sweden: 258 dataset 3). With these data, we inferred a transmissibility advantage equal to > = 259 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint

In conclusion, we found that the Alpha variant had a transmissibility advantage of +54% 262 compared to historical strains, and the Delta variant had a further transmissibility advantage of 263 +140% relative to Alpha, assuming a mean generation time of 6.5 days. There was no evidence 264 of an altered mean generation time for these two variants. Intuitive patterns in the inferred 265 relationship testify from the fact that Alpha and Delta have ( is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint not altered in these variants. C, the inferred infectivity profile of each variant with confidence intervals, together 292 with the infectivity profile of historical strains circulating before the rise of the Alpha variant (black curve). In a context of high transmission and high growth rate ("fast" epidemic), most infections will 300 be recent and it is more advantageous to transmit early. Conversely, in a context of low 301 transmission ("slow" or declining epidemic), infections will be older and it is more 302 advantageous to transmit late. The selection coefficient on variants may thus increase or 303 decrease with transmission, and it can even be a non-monotonous function of transmission. A 304 second important finding is the variation of the selection coefficient with transmission provides 305 insight on the infectivity profile. We used this understanding to infer variant infectivity profiles 306 from the variation in growth rates in contexts of changing transmission. 307

We found that Alpha variants enjoy a transmissibility advantage of +54% [45, 63] relative to 308 historical strains, and Delta variants a +140% [98, 182] additional advantage relative to Alpha. 309

Both variants have a mean generation time similar to that of historical strains (here assumed to 310 be 6.5 days). This complements previous findings: the possibility of a shorter generation time 311 was investigated to explain the growth advantage of Alpha, but previous studies found it was 312 difficult to distinguish a variant with larger transmissibility from one with a shorter generation 313 time (2,3). Some (but not all) studies of within-host viral load dynamics suggested that 314 individuals infected by variant Alpha could shed virus for a longer time, which may result in a 315 longer generation time (12-14). Conflicting results exist for Delta. A cluster of Delta variant 316 infections in China suggested a smaller mean generation time (2.9 days) and more pre-317 symptomatic transmission for Delta than early SARS-CoV-2 strains, but without good control 318 (15); more controlled studies found on the contrary a similar generation time (16,17). If the 319 distribution of generation time is similar in Delta as we infer, the observed growth rates imply 320 it is +140% more transmissible than Alpha, in line with the +70 to +200% estimated elsewhere 321 (18, 19) . If the generation time of Delta had instead been inferred 1 or 2 days shorter than the 322 baseline (6.5 days), the observed growth rate would imply the estimated transmissibility 323 . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint advantage drops to +106% or +77%. The large transmissibility advantage of Delta with similar 324 mean generation time makes it more difficult to control with interventions reducing 325 transmission (such as social distancing) than if it had a smaller transmissibility advantage 326 associated with a shorter mean generation time. 327

Our conceptual results may be useful to interpret the dynamics of variant frequency dynamics. 328 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint

In conclusion, we developed a conceptual framework to study selection on variants modifying 357 the transmission of an infectious pathogen. We decoupled selection on transmissibility (number is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. (2) 395

Conversely, the growth rate is: 396

(3) 397

The epidemic grows when ( ) > 1 and declines when ( ) < 1. Reparameterising in terms 398 of the mean and standard deviation of the gamma distribution, = and = √ , yields: 399 . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint ( ) = ( ( ) s t /u t − 1)( / ? ).

(4) 400 

The temporal variation in " ( ) thus defines a parametric relationship between " ( " ( )) and 418 ' ( " ( )) that can be used to infer > , ? and @ . The variation of the selection coefficient with 419 " ( ) is simply given by ' ( ) − " ( ). 420

To gain further intuition on the parametric relationship between " ( " ( )) and ' ( " ( )) as 422 " ( ) varies, we compute the tangent of the curve at the value " ( ) = 1 (where " is 0). The is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint approximation may still be accurate and the variance of ‰,5 will be 1/[ 5 (1 − )] where is 455 the success probability of the negative binomial. In other words, the cases number can be 456 reduced to a smaller effective cases number to account for such overdispersion. 457

The observed logit-frequency of the variant is: 458 The first two error terms are common to both growth rates and simply express the fact that both 476 growth rates will be inflated if the number of cases is by chance larger at time 1 than at time 0 477 ( ‰,> > ‰,5 ). The two last terms express the fact that estimated growth rates will be modified 478 by the error on the estimation of the frequency. For example, the growth rate of the historical 479 strain will be inflated if by chance the error term on frequency at day 0 is greater than that at 480 day 1 ( > OE•,> < 5 OE•,5 ). These terms are modulated by the true frequencies 5 and > . 481 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint Under the assumption that the errors on the logit frequencies and number of cases are 482 independent and that they are also independent between day 0 and 1, the distribution of 483 (" ,> ,' ,> ) is bivariate normal. The mean vector is: 484 The covariance between the estimated growth rates of historical and emerging strains is 492 expected to be negative, because only a fraction of cases are assayed for the presence of the 493 variant ( 5 < 5 ). Indeed, the first positive term (1/ > + 1/ 5 ) expresses the fact that positive 494 covariance will be created by error in cases number (for example, larger cases number will 495 translate into higher growth rate of both historical strains and variant). The second negative 496 term expresses the fact that the error in estimation of variant frequency will impact " ,> and ' ,> 497 in opposite ways. This second negative effect will be dominant. 498

Likelihood for temporal dynamics 500

We now formulate more generally the likelihood of observed growth rates at all days t, ̂" ,; ,̂' ,; 501 with ∈ [1, ›oe• ]. Across consecutive timepoints, successive estimates of " ,> ,' ,> will also 502 be correlated because they share the same error terms. These cross-time covariances will be: 503 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint cov[̂" ,; ,̂' ,;ž> ] = −1/ ; + 1/ ; 509 Finally, the likelihood for the estimated growth rates of historical strain and mutant within a 510 region at all days is given by the density of the multivariate normal distribution: 511 (" ,> ,' ,> , … ," ,; ¡¢£ ,' ,; ¡¢£ | ",> , … , ",; ¡¢£ , > , ? , @ ) 512 = , ĵ" ,> ,̂' ,> , … ,̂" ,; ¡¢£ ,̂' ,; ¡¢£ k (13) 513

where , is the density of the multivariate normal distribution. The mean vector is 514 composed of the true growth rates, which depend in turn on the temporal series of true 515 transmissibility of historical strains ",> , … , ",; ¡¢£ , the temporal series of true transmissibility 516 of the variant ",> (1 + > ), … , ",; ¡¢£ (1 + > ), and the distribution of the generation time of 517 the variant characterized by ? , @ . The distribution of the generation time of historical strains 518 is assumed to be known. The covariance matrix is block-diagonal with non-zero covariances 519 between mutant and historical strains at the same time and at consecutive time-points, as given 520 above. The true number of cases ; , sample size ; , and the true variant frequencies ; , 521 intervene in the expressions for the variances and covariances. In practice we approximate the 522 true number of cases and variant frequencies by their estimations, " ; and ̂;. 523

The likelihood of a series of growth rates ̂" ,¨,',¨ collected in different regions or countries 525 indexed by i is different from that for a temporal series of " ,; ,' ,; , because there are no 526 correlations between growth rates measured in different countries (in contrast to temporal 527 correlations). For such data representing spatial variation in growth rates, the mean vector is 528 composed of the true growth rates, which depend on the transmissibilities in different countries 529 ",¨. The covariance matrix has diagonal given by the variances: is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint

Our approach relies on several approximations. First, we assume that the age-of-infection 539 structure of the population is always at equilibrium with the current growth rate ( ) even 540 though transmission ( ) changes over time. Second, we assume that errors around cases 541 number and frequencies are small and normally distributed. We conducted a simulation study 542 to test our ability to infer the parameters of the variant infectivity profile in spite of these 543 approximations. 544

The simulation model is as in a previous study (24) is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; individuals in the region. Population immunity is assumed to be the same for both variants 566 (perfect cross-protection). The variable ; ;©; = ∑ j " ( , 0) + ' ( , 0)k ; 4>

is the total number of 567 individuals already infected and assumed to be fully immune at time . The instantaneous 568 reproduction number that accounts for population immunity but not for case isolation is 569 " ( ) = 5," ( ) (1 − ; ;©; / 5 ). 

We simulate the epidemiological dynamics of historical strains and variant virus. We assume 584 that historical strains initially grow slowly, while the emerging variant initially increases in 585 incidence faster thanks to its transmissibility advantage. Control measures are progressively 586 strengthened, leading to control of historical strains and then the variant. Over the period 587 considered, the variant initially increases in frequency. 588

We ran the simulation for 80 days. We first ran a simulation where we assumed the basic 589 reproduction number 5," ( ) changed as a Brownian motion with mean 1.5 and autocorrelation 590 0.05, and selected a trajectory such that the mean 5,; over the 20 first days exceeded 1.1 and 591 the mean over the 20 last days was below 0.9 (Figure 2 ). For systematic simulations designed 592 to test the inference algorithm, we chose three scenarios for the temporal variation in 5," ( ): 593 linear decline from 1.5 to 0.5, from 1.3 to 0.7, and from 1.1 to 0.9. We assumed about 9M 594 individuals are initially susceptible (corresponding to a large European region), and an initial 595 . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint number of detected cases of 4000 historical strains infections per day and 80 variant infections 596 per day. We assumed 50% of all infection are detected (probability of detection = 0.5). The 597 time to detection is the sum of time from infection to symptom onset (distributed as log-normal 598 with parameters 1.518, 0.472 (26) ), and the time from symptom to detection (distributed as 599 gamma with parameters shape 0.69, rate 0.31 (24,26)). We assumed the generation time of 600 historical strains was gamma distributed with mean 6.5 days and standard deviation 4 days (2). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Sweden. We selected countries with sufficient data (based on visual inspection of the frequency 658 trajectory of Delta), and used for each country the growth rates between the two weeks when 659 the frequency of the Delta variant passed 50%. 660

As these datasets present a limited number of weeks or countries, it was possible to directly 661 infer jointly the complete parameter set, { > , ? , ",> , … , ",; ¡¢£ } for temporal datasets, 662 { > , ? , ",> , … , ",¿ À } for the spatial dataset where Á = 11 is the number of countries. 663 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 9, 2021. ; https://doi.org/10.1101/2021.12.08.21267454 doi: medRxiv preprint

Evaluating the 678 Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Assessing 681 transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Tracking 687 SARS-CoV-2 VOC 202012/01 (lineage B. 1.1. 7) dissemination in Portugal: insights 688 from nationwide RT-PCR Spike gene drop out data

Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States

Early 694 assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 695 (B.1.1.7, variant of concern 202012/01) in France

698 Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at 699

How generation intervals shape the relationship between growth 701 rates and reproductive numbers

Roles of 704 generation-interval distributions in shaping relative epidemic strength, speed, and 705 control of new SARS-CoV-2 variants. medRxiv

SARS-CoV-2 variants of concern and variants under 707 investigation Technical Briefing 9

Public Health England. SARS-CoV-2 variants of concern and variants under 712 investigation Technical Briefing 17

Viral dynamics 717 of SARS-CoV-2 variants in vaccinated and unvaccinated individuals

CoV-2 viral dynamics in infections with variants of concern in the French community 722

Inferring SARS-CoV-2 variant within-host kinetics

Transmission Dynamics of 729 an Outbreak of the COVID-19 Delta Variant B.1.617.2 -Guangdong Province

Serial intervals 732 observed in SARS-CoV-2 B.1.617.2 variant cases. medRxiv

Serial interval and transmission dynamics 735 during the SARS-CoV-2 Delta variant predominance in South Korea

Rapid spread of the SARS-CoV-2 δ variant in the area of Paris

Spread 742 of the Delta variant, vaccine effectiveness against PCR-detected infections and within-743 host viral load dynamics in the community in France

The SARS-CoV-2 B.1.351 lineage (VOC β) is outgrowing the 747 B.1.1.7 lineage (VOC α) in some French regions in

Monitoring key epidemiological parameters of SARS-CoV-2 transmission

SARS-CoV-2 variants of concern are associated with lower RT-754 PCR amplification cycles between

SARS-CoV-2 variants of concern and variants under 757 investigation in England

Belloir A, Blanquart F. Estimating the global reduction in transmission and rise in 762 detection capacity of the novel coronavirus SARS-CoV-2 in early 2020

Estimating 765 the effects of non-pharmaceutical interventions on COVID-19 in Europe

The Incubation 768 Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed 769 Cases: Estimation and Application

Core Team. R: A Language and Environment for Statistical Computing. Vienna, 771 Austria: R Foundation for Statistical Computing

Data on SARS-CoV-2 variants in the EU/EEA

European Centre for Disease 773 Prevention and Control

Points are the estimated growth rates with error, the curves show local polynomial 784 regression (loess). The selection coefficient is the vertical distance to the bisector. A variant with a shorter mean 785 generation time presents a steeper relationship between the two growth rates (light blue curve), meaning that the 786 selection coefficient is maximal when transmission is large (fast growing epidemic) (Figure 1C, D)

Acknowledgements: FB was funded by a Momentum grant from CNRS. We thank Public